Startup Spotlight at BioPharm America
A pitch competition featuring the most innovative startup biotech companies during BioPharm America.
Applications for Startup Spotlight at BioPharm America are now closed
If you would like more information on next years Startup Spotlight at BioPharm America please email Olivia Guiliana at oguiliana@ebdgroup.com
Congratulations to our Startup Spotlight at BioPharm America 2023 Winner
Damon Race, President and CEO of GeneVentiv Therapeutics, Inc. was chosen as the winner by the judges.
Startup Spotlight at BioPharm America 2023 Presenters
Congratulations to the selected startup companies. Join us for the Startup Spotlight at BioPharm America on September 14 at 3:45pm.
Startup Spotlight Judges
BENEFITS OF PRESENTING AT THE STARTUP SPOTLIGHT
We understand as an early-stage company you face many challenges, including getting in front of the right people. The Startup Spotlight is designed to provide you with an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take your startup to the next level.
VISIBILITY
Generate interest among top-tier investors and pharma execs through a company pitch
CONNECT
Have conversations with potential investors and partners onsite at BioPharm America
ACQUIRE
Attain funding, infrastructure, and mentorship
Criteria & Pricing
Startup Company Criteria
Startup companies that meet the following criteria are encouraged to apply
- Created in the past three years
- Has fewer than 10 employees
- Aggregate financing of 5 million USD or less
- Developing new therapeutic products, technology platforms, or digital medicine technologies
Fee Structure
- Pitch fee: $195.00*
- Discounted BioPharm America rate: $495.00
- Total pitch package fee: $690.00
*Qualifying criteria must be met for this rate
Pitch Details
- 4-minute company pitch with 5 slides
- Judges choice winner will get a ticket to an EBD Group conference of their choice
Need help?
Please direct any questions to:
Olivia Guilliana
EBD Group
oguiliana@ebdgroup.com